Holen Sie sich die Stockscreener-App
5.87
1.03%
0.06
Cytek Biosciences Inc Aktie (CTKB) Neueste Nachrichten
Cytek Biosciences unveils new cloud platform for seamless lab data analysis - Traders Union
Cytek introduces new end-to-end flow cytometry workflow - Select Science
Cytek Biosciences, Inc. (CTKB) Stock Price, News, Quote & History - Yahoo! Finance Canada
Cytek Biosciences Adopts Amended Bylaws Tightening Stockholder Nomination Rules - Minichart
Form 8K Cytek Biosciences Inc For: 29 September By Investing.com - Investing.com Nigeria
Fund Divests Cytek Biosciences (CTKB) Following Revenue Slowdown and Declining Profitability - Yahoo Finance
Cytek Biosciences launches Cloud Analysis within Cytek Cloud digital ecosystem - Traders Union
Cytek Biosciences launches cloud-based analysis tool - Investing.com
Cytek Biosciences launches cloud-based analysis tool By Investing.com - Investing.com Canada
Cytek Biosciences Expands Cytek Cloud with New Cloud Analysis Tool for End-to-End Flow Cytometry Workflow - Quiver Quantitative
A new tool lets researchers analyze cell data online without rebuilding their work - Stock Titan
Cytek Biosciences stock gains 2.25 percent near its yearly range - AD HOC NEWS
Cytek Biosciences stock trades near recent lows after valuation update - AD HOC NEWS
Cytek Biosciences stock edges higher after recent earnings and analyst interest - AD HOC NEWS
Cytek and Sysmex Europe team up to expand access to advanced clinical flow cytometry - Select Science
Is the Options Market Predicting a Spike in Cytek Biosciences Bank Stock? - finance.yahoo.com
Transcript : Cytek Biosciences, Inc. Presents at Morgan Stanley 24th Annual Global Healthcare Conference, Sep-16-2026 09 - marketscreener.com
Cytek at Morgan Stanley global healthcare conference: growth broadens - Investing.com
Cytek at Morgan Stanley global healthcare conference: growth broadens By Investing.com - Investing.com UK
Cytek Biosciences, Sysmex Europe Collaborate to Deliver Clinical Flow Cytometry Workflows - marketscreener.com
Sysmex Europe SE And Cytek Biosciences, Inc Collaborate To Expand Access To Advanced Clinical Flow Cytometry - marketscreener.com
Sysmex Europe SE and Cytek Biosciences Announce Strategic Collaboration to Expand Clinical Flow Cytometry Access Across Europe - Quiver Quantitative
Sysmex Europe and Cytek® Biosciences Collaborate to Expand Access to Advanced Clinical Flow Cytometry - Yahoo Finance
CTKB Q2 2026 Earnings: Narrower-Than-Expected Loss Lifts SharesEarnings Decline Risk - dars.gov.et
Cytek’s (CTKB) Instruments Keep Selling While Losses Keep Growing - Yahoo Finance
Cytek Biosciences to Showcase Spectral Flow Cytometry Solutions at ESCCA 2026 and ICCS 2026 - Quiver Quantitative
Cytek Biosciences Showcases Advanced Spectral Flow Cytometry Solutions At Escca and Iccs - marketscreener.com
More than 4,200 peer-reviewed papers cite Cytek’s systems. It will showcase them at two fall meetings. - Stock Titan
Cytek Biosciences (CTKB) officer plans $146K share sale - Stock Titan
Cytek Biosciences stock holds near recent levels as investor conferences approach - AD HOC NEWS
Cytek Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
Cytek Owes Beckman Coulter $56 Million at Patent Jury Trial (2) - Bloomberg Law News
Cytek (CTKB) Earnings Report: EPS Clears the Reported Estimate in Latest Trading; Price Reaction: Shares Finish 3.22% Up in the Latest SessionPre-Announcement Alert - vinanet.vn
Cytek Hit With $56M Verdict For Infringing Cell-Sorting Patent - Law360
Cytek Biosciences wins on three of four patent claims - Investing.com
Cytek Biosciences wins on three of four patent claims By Investing.com - Investing.com Nigeria
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says - Reuters
Jury Finds in Cytek’s Favor on Three of Four Asserted Claims; Company to Challenge Remaining Finding - marketscreener.com
Cytek products remain available worldwide after jury awards $36M in royalties - Stock Titan
Cytek Biosciences CFO William D. McCombe Executes RSU Vesting and Tax Withholding Transactions - Kalkine Media
Cytek Biosciences Director Glenn P. Muir Converts 3,086 RSUs to Common Stock on August 18, 2026 - Kalkine Media
Cytek Biosciences (CTKB) CEO gets 120K shares, surrenders some for taxes - Stock Titan
Cytek Biosciences (NASDAQ: CTKB) director gains 3,086 no-cost shares - Stock Titan
Cytek Biosciences (CTKB) director now holds 28,499 shares - Stock Titan
Cytek Biosciences (CTKB) CTO gets 33,270 shares, surrenders some for taxes - Stock Titan
Cytek (CTKB) Quarterly Figures: EPS Prints Above Forecast in the Latest Session; Stock Move: Shares Finish 0.96% HigherEstimate Dispersion - vinanet.vn
Cytek Biosciences Balances Growth With Profit Pressures - TipRanks
Cytek (CTKB) Q2 2026 Earnings Call Transcript - AOL.com
Cytek Biosciences (CTKB) awards 241,416 RSUs and 127,118 options to top lawyer - Stock Titan
Cytek Biosciences: Recurring Revenue Reaches 35% Of Sales As Installed Base Approaches 4,000 Instruments - Pulse 2.0
Cytek Biosciences launches Aurora Evo system to drive high-throughput research and small particle detection - Traders Union
Promising Penny Stocks To Consider In August 2026 - simplywall.st
Cytek Biosciences (NASDAQ:CTKB) Trading 8.5% HigherShould You Buy? - MarketBeat
Cytek Biosciences, Inc. (8EQ.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH), Cytek Biosciences (CTKB) and Sight Sciences (SGHT) - The Globe and Mail
Cytek Biosciences, Inc. (CTKB) interactive stock chart – Yahoo Finance - Yahoo Finance Singapore
Cytek Biosciences (CTKB) holders report over 7% stakes in Schedule 13G/A - Stock Titan
Cytek Biosciences, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Morgan Stanley Maintains Cytek Biosciences(CTKB.US) With Hold Rating, Cuts Target Price to $5 - Moomoo
0.26%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):